[Management of parasitic intestinal diseases].
D000563:Amebicides / Q000627:therapeutic use*; D000871:Anthelmintics / Q000627:therapeutic use; D001447:Balantidiasis / Q000188:drug therapy; D001938:Brazil; D002738:Chloroquine / Q000627:therapeutic use; D002739:Chloroquinolinols / Q000627:therapeutic use; D004404:Dysentery, Amebic / Q000188:drug therapy; D004640:Emetine / Q000627:therapeutic use; D005664:Furazolidone / Q000627:therapeutic use; D005873:Giardiasis / Q000188:drug therapy; D006801:Humans; D007411:Intestinal Diseases, Parasitic / Q000188:drug therapy*; D008795:Metronidazole / Q000627:therapeutic use; D010118:Oxytetracycline / Q000627:therapeutic use; D010303:Paromomycin / Q000627:therapeutic use; D011804:Quinolines / Q000627:therapeutic use*
D000563:Amebicides; D000871:Anthelmintics; D002739:Chloroquinolinols; D011804:Quinolines; D008795:Metronidazole; D005664:Furazolidone; D010303:Paromomycin; D002738:Chloroquine; D010118:Oxytetracycline; D004640:Emetine
Tratamento das parasitoses intestinais.